Cocrystal Pharma, Inc.

8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 3, 2026 8-K Shareholder vote results Jul 17, 2026 8-K Director or officer change Jun 9, 2026 8-K Regulation FD disclosure Jun 3, 2026 8-K Regulation FD disclosure May 26, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Regulation FD disclosure Apr 30, 2026 8-K Regulation FD disclosure Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Director or officer change Mar 13, 2026 8-K Regulation FD disclosure Mar 9, 2026 8-K Regulation FD disclosure Feb 19, 2026 8-K Director or officer change Jan 15, 2026 8-K Regulation FD disclosure Dec 18, 2025 8-K Regulation FD disclosure Dec 1, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 30, 2025 8-K Regulation FD disclosure Oct 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 15, 2025 8-K Regulation FD disclosure Sep 12, 2025 8-K Regulation FD disclosure Sep 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Regulation FD disclosure Aug 5, 2025 8-K Regulation FD disclosure Jul 10, 2025 8-K Shareholder vote results Jul 1, 2025 8-K Amended charter or bylaws Jun 18, 2025 8-K Regulation FD disclosure Jun 5, 2025 8-K Regulation FD disclosure May 29, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Regulation FD disclosure Apr 24, 2025 8-K Regulation FD disclosure Apr 23, 2025 8-K Director or officer change Apr 8, 2025 8-K Other events Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Regulation FD disclosure Jan 13, 2025